Completely updated and revised, Clinical Tuberculosis continues to provide the TB practitioner-whether in public health, laboratory science or clinical practice-with a synoptic and definitive account of the latest methods of diagnosis, treatment and control of this challenging and debilitating disease.New in the Fifth Edition:Gamma interferon-based
|Author||: North Carolina. State Board of Health|
|Release Date||: 1947|
|Pages||: 88 pages|
Every second a new person is exposed to tuberculosis (TB). Each untreated TB-infected person will infect 10-15 people every year. Following the success of its predecessor, this new edition of Tuberculosis: The Essentials scrutinizes the new discoveries and observations of the key aspects of the disease. Recognized world experts provide a concise, state-of-the-art review of the 15 essential elements of TBsupply an international, current view of the epidemiology, pathophysiology, diagnosis, and treatment methodsdiscuss the emerging threat of XDR-TB and the HIV/AIDS factorassess advances in TB research such as new drugs and vaccinesreflect on the progress of the "Stop TB" strategy. See What’s New in the Fourth Edition: Updated chapters on epidemiology and pathogenesis provide new insights on TB infection and disease Updated chapters on diagnosis and treatment cover new tests and molecular detection methods Information on developing effective regiments and discussion of situations deserving specific precautions Coverage of adherence issues The book book is an essential guide for everybody working in the field of TB, from specialists to nurses and students, both from a clinical and public health perspective.
|Author||: United States. Agricultural Research Service. Animal Disease Eradication Division|
|Release Date||: 1957|
|Pages||: 329 pages|
|Author||: United States. Joint Commission on Indian Tuberculosis Sanitarium and Yakima Indian Reservation Project|
|Release Date||: 1914|
|Pages||: 375 pages|
This work contains updated and clinically relevant information about tuberculosis. It is aimed at providing a succinct overview of history and disease epidemiology, clinical presentation and the most recent scientific developments in the field of tuberculosis research, with an emphasis on diagnosis and treatment. It may serve as a practical resource for students, clinicians and researchers who work in the field of infectious diseases.
In 1917, as the United States prepared for war in Europe, Army Surgeon General William C. Gorgas recognized the threat of Mycobacterium tuberculosis to American troops. What the Army needed was some "good tuberculosis men." Despite the efforts of the nations best "tuberculosis men," the disease would become a leading cause of World War I disability discharges and veterans benefits. The fact that tuberculosis patients often experienced cycles in which they recovered their health and then fell ill again challenged government officials to judge the degree to which a person was disabled and required government care and support. This book tracks the impact of tuberculosis on the US Army from the late 1890s, when it was a ubiquitous presence in society, to the 1960s when it became a curable and controllable disease.
What Is Tuberculosis?: Its Control and Prevention provides an introduction to the understanding of tuberculosis, a contagious lung disease caused by tubercle bacillus. This book discusses the characteristics, causes, treatment, control, and prevention of this disease. Organized into two parts encompassing 85 chapters, this book begins with an overview of the nature of the problem of tuberculosis. This text then explores the characteristics of tubercle bacillus, which is very resistant and can live for a long time outside the body especially in damp dark places. Other chapters consider the modes of infection and explain how bacillus tuberculosis enters the body by inhalation and by ingestion. This book discusses as well the most dangerous source of infection, namely, a patient with open tuberculosis of the lungs. The final chapter deals with tuberculosis as a useful index of the social and economic conditions of a community. This book is a valuable resource for physicians and scientists.
With over 10 million new TB cases and 1.6 million deaths, TB is a global health priority. Multidrug-resistant TB is of particular concern to both clinicians and national TB programmes: in 2017, there were 558 000 new rifampicin-resistant cases and 460 000 confirmed multidrug-resistant TB cases. Despite extensive investigation over the years, there is still a great deal to learn about the prevention, diagnosis and treatment of TB. This Monograph brings together chapters from global TB experts and begins with a patients’ perspective that sets the tone. The following chapters cover: the history of TB; epidemiology; strategies for control and elimination; clinical and laboratory diagnosis; imaging; treatment and drugs; TB in children and different patient populations; comorbidities; clinical cases; and much more.